You share your most personal medical details online, trusting that privacy policies mean something. Then the federal government steps in to say those promises were broken.
The Federal Trade Commission, alongside the states of California and Utah, filed a major federal lawsuit against the popular telehealth platform Hims & Hers Health. The complaint accuses the San Francisco-based company of quietly transmitting sensitive user health information to major advertising platforms like Meta and Snap. It also targets deceptive billing routines and subscription traps that catch patients off guard.
If you've ever filled out an online intake form for hair loss treatments, weight-loss drugs, or sexual wellness products, this case hits close to home.
What the Lawsuit Actually Alleges
The core issue centers on trust and tracking. When people visit health websites, they expect medical confidentiality. According to the FTC's complaint filed in the U.S. District Court for the Northern District of California, Hims & Hers used third-party tracking technologies and customer list matching. These systems automatically transmitted visitors' browsing behavior and health conditions directly to social media giants.
The agency highlights that conditions like erectile dysfunction, premature ejaculation, and weight struggles are precisely what users want kept quiet. Broadcasting those medical interests to ad networks destroys any illusion of privacy.
Beyond data sharing, regulators target deceptive financial habits. The FTC claims that Hims & Hers charges consumers for prescriptions almost immediately after they finish an online intake form. That happens before the patient ever speaks with a licensed medical professional.
Patients often think they are just filling out an application to see if a treatment fits their needs. Instead, they find their credit cards billed instantly and get locked into recurring monthly subscriptions. To make matters worse, the lawsuit states that the company intentionally hid its online cancellation button behind a confusing multi-step maze.
The Company Responds
Hims & Hers pushed back hard against the allegations. In public statements posted shortly after the filing, the company dismissed the federal action as baseless.
Representatives argued that the lawsuit ignores standard telehealth industry practices and disregards the evidence provided during a nearly three-year federal investigation. The firm maintains that its privacy policy clearly informs users how data operates and insists that actual medical consultations remain strictly confidential between patients and clinicians.
Wall Street reacted swiftly. Shares of Hims & Hers dropped sharply following the announcement, wiping out a chunk of market value as investors processed the regulatory fallout.
Why This Matters for Digital Health
The case serves as a warning shot for the entire direct-to-consumer digital health sector. For years, direct-to-consumer health brands relied heavily on aggressive social media retargeting pixels to scale their customer acquisition funnels.
When tracking pixels collect page views tied to sensitive medical inquiries, they cross a legal line. Regulators are drawing a hard boundary between standard e-commerce tracking and healthcare privacy.
If you use telehealth apps, you need to pay close attention to how your data moves behind the scenes. Always check privacy policies for data-sharing loopholes, and monitor your credit card statements closely after submitting online intake forms.
The era of unchecked medical data sharing on ad networks is coming to an end. Regulators are watching, and companies that prioritize rapid growth over user confidentiality are paying the price.
